NanoString and Visiopharm Announce Collaboration to Co-develop Integrated Workflows for GeoMx and AtoMx Spatial Biology Solutions

Collaboration to unify NanoString’s best-in-class spatial biology platforms with Visiopharm’s AI-driven image analysis capabilities to enable integrated end-to-end workflows for translational research studies. SEATTLE–(BUSINESS WIRE)–#spatialbiology–NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, and Visiopharm, a world leader in AI-driven digital pathology software, today announced a collaboration … [Read more…]

BioAge Labs to Present Data on Novel Brain-Penetrant NLRP3 Inhibitors for Treatment of Neurodegeneration and Brain Aging at Upcoming Conferences

Family of NLRP3 inhibitors is differentiated by novel structure, central nervous system penetration, and potential for improved safety and efficacy RICHMOND, Calif.–(BUSINESS WIRE)–#aging–BioAge Labs, Inc. (“BioAge”), a privately held clinical-stage biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, today announced that it will present updates on its … [Read more…]

Global Sleep Apnea Devices Market Report (2022 to 2027) – Industry Trends, Share, Size, Growth, Opportunity and Forecasts – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Sleep Apnea Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global sleep apnea devices market size reached US$ 7.0 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 10.5 Billion by 2027, exhibiting a CAGR of 6.99% … [Read more…]

2022 Report on Antibiotics Companies in China – Identify Business Opportunities and Promote Product Sales in Chinese Markets – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Antibiotics Companies in China” report has been added to ResearchAndMarkets.com’s offering. This study focuses on China’s Antibiotics industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of manufacturing capabilities and rising consumer consumption in China have transformed China’s society and … [Read more…]

Wyss Center for Bio and Neuroengineering: New Horizons in Neural Recording Systems

New whitepaper reveals first brain signals recorded by the ABILITY system and the next steps to human clinical trials for people with severe paralysis GENEVA–(BUSINESS WIRE)–#BCI–A new whitepaper, released by the Wyss Center for Bio and Neuroengineering, reveals the first neural signals recorded by the ABILITY brain-computer interface (BCI) system. It also lays out the … [Read more…]

Global Cancer/Tumor Profiling Market Research Report to 2027 – Increasing Demand for Personalized Medicine Presents Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cancer/Tumor Profiling Market Research Report by Technology, Cancer Type, Biomarker Type, Application, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Cancer/Tumor Profiling Market size was estimated at USD 9,872.31 million in 2021, USD 11,656.24 million in 2022, and is projected to … [Read more…]

Olleco and Bunge Agree to Joint Venture to Create a Full Life-Cycle Oil Collection Business in Europe

ST. LOUIS & SHREWSBURY U.K.–(BUSINESS WIRE)–Bunge (NYSE: BG), a leading producer of plant-based oils, and Olleco, the renewables division for ABP Food Group, today announced an agreement to form a 50/50 joint venture to create a business that encompasses the full life-cycle of edible oils. The joint venture is expected to work with foodservice and … [Read more…]

4Moving Biotech Announces First Patient Enrolled in Phase I Clinical Trial on Osteoarthritis

LILLE, France–(BUSINESS WIRE)–#1stpatient—4Moving Biotech, a biotechnology company and subsidiary of 4P-Pharma, focusing on the development of a first-in-class disease modifying osteoarthritis drug (DMOAD) for a curative treatment of osteoarthritis, announces that it has enrolled its first patient for phase I of LASARE clinical trial study. “We are so excited to have the first patient enrolled … [Read more…]

SpectrumX Announces Lab Data Showing Its Spectricept™ Product Neutralises C. difficile Spores Within Minutes

Lab tests shows that Spectricept™ neutralises a variety of common pathogens, including the spores of C. difficile, which are commonly found in hospitals and health care facilities and are a cause of hospital-acquired infection. Patent-pending formula benefiting from the sporicidal qualities of hypochlorous acid (HOCl) is pH neutral and skin-safe, with a ‘kill time’ of … [Read more…]

Inovia Vein Specialty Centers Brings DVT Awareness to Oregon

Join the World Thrombosis Day Campaign on October 13 OREGON–(BUSINESS WIRE)–#EyesOpentoThrombosis–October 13th is World Thrombosis Day. Inovia Vein Specialty Centers is joining other healthcare experts around the world to raise awareness about this important subject. Thrombosis is a formation of blood clot known as Thrombus which forms and stays in blood vessels. Thrombosis can occur … [Read more…]